Riddhi Siddhi Gluco Biols Limited

Riddhi Siddhi Gluco Biols Limited

BBSE:RIDDHI
660.10
INR
-36.55
(-5.25%)
21.65EPS
5.35BMarket Cap
Riddhi Siddhi Gluco Biols Limited
BSE:RIDDHI
(Bombay Stock Exchange)

Recent

price

660.10

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
INR
6.21
22.99
501.99
513.18
55.06
479.7
706.99
1,122.17
931.01
804.4
694.61
312.03
241.42
375.2
189.47
330.04
253.38
Revenue per Share
147.22
55.44
23.48
4.45
2.52
55.65
-59.96
26.59
68.35
46.11
-65.62
3.12
-77.9
65.5
7.3
-6.28
-14.05
Basic EPS, GAAP
-57.63
-45.64
-432.83
88.34
3.68
-21.69
-427.26
-47.03
-1.8
163.16
182.26
226.2
0.75
12.49
-39.7
-12.96
- -
Free Cash Flow per Basic Share
5.36
13.89
25.42
10.39
3.92
3.58
3
2.02
- -
2
- -
- -
1
1.5
3
3
- -
Dividend per Share
320.64
1,065.84
1,077.59
1,078.53
1,284.11
1,915.89
1,854.45
1,946.66
2,012.09
1,998.1
2,037.63
2,110.07
2,008.47
2,155.44
2,172.7
2,116.79
- -
Book Value per Share
320.63
1,065.84
1,077.59
1,078.53
1,284.11
1,914.37
1,853.08
1,945.57
2,011.29
1,997.59
2,037.41
2,109.89
2,008.31
2,155.29
2,172.58
2,116.69
- -
Tangible Book Value per Share
11
10
9
9
8
7
7
7
7
7
7
7
7
7
7
7
7
Basic Weighted Avg Shares
69
237
4,755
4,860
456
3,420
5,045
8,000
6,638
5,735
4,952
2,225
1,721
2,675
1,351
2,353
1,711
Sales/Revenue/Turnover
-7.46
-57.19
-1.52
-2.15
26.34
6.1
-15.05
-3.63
13.62
2.53
-10.27
6.39
-6.34
-1.81
-4.11
-8.52
-13.54
Operating Margin (%)
30
371
287
246
170
284
348
342
347
366
375
369
301
107
85
82
85
Depreciation Expense
1,645
576
227
47
26
402
-428
190
487
329
-468
22
-555
467
52
-45
-95
Net Income, GAAP
- -
- -
20.87
15.44
91.41
25.68
- -
- -
7.76
20.36
- -
24.2
31.07
11.62
11.8
33.24
31.12
Effective Tax Rate (%)
2,378.86
243.14
4.78
0.96
5.63
11.74
-8.48
2.37
7.34
5.73
-9.45
1
-32.27
17.46
3.85
-1.9
-5.55
Profit Margin (%)
-1,040
9,634
9,427
9,562
8,596
7,766
7,068
6,533
5,778
6,437
3,076
3,832
5,371
5,109
4,282
5,159
- -
Working Capital
303
1,349
1,203
1,109
918
2,257
1,892
1,645
1,155
865
812
733
15
20
15
1,671
- -
LT Debt
3,572
10,102
10,214
10,223
9,164
14,738
15,010
15,568
16,006
15,580
15,522
15,915
14,897
15,917
15,866
15,390
- -
Total Equity
- -
- -
1.97
0.41
0.23
2.95
- -
- -
3.78
0.65
- -
0.55
-0.45
-0.4
-0.32
-0.76
- -
Return on Invested Capital (%)
- -
- -
1.97
0.96
0.3
3.77
- -
- -
3.22
3.45
- -
1.13
-1.26
3.55
1.85
0.83
- -
Return on Capital (%)
57.64
8.36
2.19
0.41
0.22
3.47
-3.18
1.4
3.45
2.3
-3.25
0.15
-3.78
3.15
0.34
-0.29
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
1,156
- -
LT Borrowings
- -
1,671
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
7
7
7
Market Capitalization
2,996
2,942
5,346

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
6,937
- -
Cash, Cash Equivalents & STI
- -
1,102
- -
Accounts Receivable, Net
- -
82
- -
Inventories
- -
438
- -
Total Current Liabilities
- -
1,778
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
1,156
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
0.5%
-0.07%
-3%
Free Cash Flow
-645.13%
200.47%
-67.36%
Net Income, GAAP
-363.17%
-632.6%
-186.1%
Sales/Revenue/Turnover
6.42%
0.48%
74.19%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
143
489
443
280
1,351
2026
1,546
321
401
91
2,353
2027
899
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
33.5
18.7
-50.56
6.49
7.3
2026
11.27
19.29
-1.81
-45.92
-6.28
2027
4.21
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
3
2026
- -
- -
- -
- -
3
2027
- -
- -
- -
- -
- -
Business
Riddhi Siddhi Gluco Biols Limited manufactures starch and its derivatives, along with co-products from corn wet milling; core products include native starch, liquid glucose, dextrose monohydrate, dextrose syrup, high maltose corn syrup, maltodextrin, and byproducts such as corn gluten meal and enriched fiber; the company also produces specialty modified starches through its biopolymer division and engages in trading agricultural and metal commodities, wind power generation, packaged water bottling, and kraft paper manufacturing. Founded in 1990 and headquartered in Ahmedabad, Gujarat, India, with manufacturing facilities in Viramgam (Gujarat), Gokak (Karnataka), Pondicherry, and Pantnagar (Uttarakhand), Riddhi Siddhi Gluco Biols Limited serves diverse sectors including food and beverages, pharmaceuticals, paper, textiles, and brewing, with marquee clients such as Nestle, Cadbury, Pfizer, ITC, and Grasim; it exports products internationally and operates as a subsidiary of Creelotex Engineers Private Limited. In recent developments, the company approved a Rs 50 crore related party loan to its subsidiary, reappointed key management including Managing Director Ganpatraj L. Chowdhary, and reported consolidated net profit growth to Rs 13.54 crore for the quarter ended September 2025 amid ongoing diversification beyond its legacy starch operations.